192 related articles for article (PubMed ID: 33441772)
1. High cut-off dialysis mitigates pro-calcific effects of plasma on vascular progenitor cells.
Schaub T; Janke D; Zickler D; Lange C; Girndt M; Schindler R; Dragun D; Hegner B
Sci Rep; 2021 Jan; 11(1):1144. PubMed ID: 33441772
[TBL] [Abstract][Full Text] [Related]
2. In Vitro Dialysis of Cytokine-Rich Plasma With High and Medium Cut-Off Membranes Reduces Its Procalcific Activity.
Willy K; Hulko M; Storr M; Speidel R; Gauss J; Schindler R; Zickler D
Artif Organs; 2017 Sep; 41(9):803-809. PubMed ID: 28524237
[TBL] [Abstract][Full Text] [Related]
3. Targeting proinflammatory cytokines ameliorates calcifying phenotype conversion of vascular progenitors under uremic conditions in vitro.
Hegner B; Schaub T; Janke D; Zickler D; Lange C; Girndt M; Jankowski J; Schindler R; Dragun D
Sci Rep; 2018 Aug; 8(1):12087. PubMed ID: 30108259
[TBL] [Abstract][Full Text] [Related]
4. High cut-off dialysis in chronic haemodialysis patients reduces serum procalcific activity.
Zickler D; Willy K; Girndt M; Fiedler R; Martus P; Storr M; Schindler R
Nephrol Dial Transplant; 2016 Oct; 31(10):1706-12. PubMed ID: 27445317
[TBL] [Abstract][Full Text] [Related]
5. Expanded Haemodialysis Therapy of Chronic Haemodialysis Patients Prevents Calcification and Apoptosis of Vascular Smooth Muscle Cells in vitro.
Willy K; Girndt M; Voelkl J; Fiedler R; Martus P; Storr M; Schindler R; Zickler D
Blood Purif; 2018; 45(1-3):131-138. PubMed ID: 29402827
[TBL] [Abstract][Full Text] [Related]
6. Uremic Patients with Increased Vascular Calcification Score Have Serum with High Calcific Potential: Role of Vascular Smooth Muscle Cell Osteoblastic Differentiation and Apoptosis.
Ciceri P; Galassi A; Alfieri C; Messa P; Cozzolino M
Blood Purif; 2019; 48(2):142-149. PubMed ID: 30726841
[TBL] [Abstract][Full Text] [Related]
7. Growth Arrest-specific 6 Protein and Matrix Gla Protein in Hemodialysis Patients.
Hallajzadeh J; Ghorbanihaghjo A; Argani H; Dastmalchi S; Rashtchizadeh N
Iran J Kidney Dis; 2015 May; 9(3):249-55. PubMed ID: 25957430
[TBL] [Abstract][Full Text] [Related]
8. Vascular Calcification Markers and Hemodialysis Vascular Access Complications.
Lyu B; Banerjee T; Scialla JJ; Shafi T; Yevzlin AS; Powe NR; Parekh RS; Astor BC
Am J Nephrol; 2018; 48(5):330-338. PubMed ID: 30380526
[TBL] [Abstract][Full Text] [Related]
9. Medium Cut-Off (MCO) Membranes Reduce Inflammation in Chronic Dialysis Patients-A Randomized Controlled Clinical Trial.
Zickler D; Schindler R; Willy K; Martus P; Pawlak M; Storr M; Hulko M; Boehler T; Glomb MA; Liehr K; Henning C; Templin M; Trojanowicz B; Ulrich C; Werner K; Fiedler R; Girndt M
PLoS One; 2017; 12(1):e0169024. PubMed ID: 28085888
[TBL] [Abstract][Full Text] [Related]
10. Adventitial MSC-like Cells Are Progenitors of Vascular Smooth Muscle Cells and Drive Vascular Calcification in Chronic Kidney Disease.
Kramann R; Goettsch C; Wongboonsin J; Iwata H; Schneider RK; Kuppe C; Kaesler N; Chang-Panesso M; Machado FG; Gratwohl S; Madhurima K; Hutcheson JD; Jain S; Aikawa E; Humphreys BD
Cell Stem Cell; 2016 Nov; 19(5):628-642. PubMed ID: 27618218
[TBL] [Abstract][Full Text] [Related]
11. The Strategy to Prevent and Regress the Vascular Calcification in Dialysis Patients.
Chen NC; Hsu CY; Chen CL
Biomed Res Int; 2017; 2017():9035193. PubMed ID: 28286773
[TBL] [Abstract][Full Text] [Related]
12. Role of vascular calcification inhibitors in preventing vascular dysfunction and mortality in hemodialysis patients.
Gungor O; Kocyigit I; Yilmaz MI; Sezer S
Semin Dial; 2018 Jan; 31(1):72-81. PubMed ID: 28608927
[TBL] [Abstract][Full Text] [Related]
13. The importance of fetuin-A in vascular calcification in children with chronic kidney disease.
Makulska I; Szczepańska M; Drożdż D; Polak-Jonkisz D; Zwolińska D
Adv Clin Exp Med; 2019 Apr; 28(4):499-505. PubMed ID: 30070080
[TBL] [Abstract][Full Text] [Related]
14. Functional genomic analysis identifies indoxyl sulfate as a major, poorly dialyzable uremic toxin in end-stage renal disease.
Jhawar S; Singh P; Torres D; Ramirez-Valle F; Kassem H; Banerjee T; Dolgalev I; Heguy A; Zavadil J; Lowenstein J
PLoS One; 2015; 10(3):e0118703. PubMed ID: 25811877
[TBL] [Abstract][Full Text] [Related]
15. Removal of uremic retention products by hemodialysis is coupled with indiscriminate loss of vital metabolites.
Zhang ZH; Mao JR; Chen H; Su W; Zhang Y; Zhang L; Chen DQ; Zhao YY; Vaziri ND
Clin Biochem; 2017 Dec; 50(18):1078-1086. PubMed ID: 28928007
[TBL] [Abstract][Full Text] [Related]
16. The Place of Large Pore Membranes in the Treatment Portfolio of Patients on Hemodialysis.
Van Biesen W; Vanholder R; Schepers E; Glorieux G; Dhondt A; Eloot S
Contrib Nephrol; 2017; 191():168-177. PubMed ID: 28910800
[TBL] [Abstract][Full Text] [Related]
17. High cut-off dialysis in chronic haemodialysis patients.
Girndt M; Fiedler R; Martus P; Pawlak M; Storr M; Bohler T; Glomb MA; Liehr K; Henning C; Templin M; Trojanowicz B; Ulrich C; Werner K; Zickler D; Schindler R
Eur J Clin Invest; 2015 Dec; 45(12):1333-40. PubMed ID: 26519693
[TBL] [Abstract][Full Text] [Related]
18. Randomized controlled pilot study of 2 weeks' treatment with high cutoff membrane for hemodialysis patients with elevated C-reactive protein.
Fiedler R; Neugebauer F; Ulrich C; Wienke A; Gromann C; Storr M; Böhler T; Seibert E; Girndt M
Artif Organs; 2012 Oct; 36(10):886-93. PubMed ID: 22845695
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic Efficacy and Cost Effectiveness of High Cut-Off Dialyzers Compared to Conventional Dialysis in Patients with Cast Nephropathy.
Curti A; Schwarz A; Trachsler J; Tomonaga Y; Ambühl PM
PLoS One; 2016; 11(7):e0159942. PubMed ID: 27467401
[TBL] [Abstract][Full Text] [Related]
20. Serum sclerostin: the missing link in the bone-vessel cross-talk in hemodialysis patients?
Pelletier S; Confavreux CB; Haesebaert J; Guebre-Egziabher F; Bacchetta J; Carlier MC; Chardon L; Laville M; Chapurlat R; London GM; Lafage-Proust MH; Fouque D
Osteoporos Int; 2015 Aug; 26(8):2165-74. PubMed ID: 25910747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
